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We compared the accuracy of genotyping forDNA extracted from lymphocytes to that of
DNA amplified from buccal epithelial cells.
Amplification was via a rolling circle/φ29 DNA poly-
merase commercial kit. Paired buccal and
lymphocyte DNA samples were available from 30
individuals. All samples were genotyped for 12
SNPs, 5 microsatellites and 2 VNTRs. The accuracy
of genotyping (no-call proportions, reproducibility,
and concordance) was similar for DNA from lympho-
cytes in comparison to amplified DNA from buccal
samples. If used with caution, these data suggest
that rolling-circle whole-genome amplification can be
used to increase the DNA mass available for large-
scale genotyping projects based on DNA from
buccal cells.
Many twin registries have collected DNA via buccal
epithelial cell-brush or mouthwash protocols. The
choice of this method of DNA collection was due to
its low subject burden and relatively small expense
(10–20% of the cost of collection of a peripheral
venous sample). However, the disadvantage of buccal
DNA collection is the lesser quantity and poorer
quality of DNA in comparison to DNA derived from
lymphocytes. Many investigators now wish to geno-
type their twin samples for a large number of markers
and the DNA mass required for these genotyping
reactions often exceeds the DNA yield of most buccal
DNA extraction protocols.
Recently, several whole-genome amplification pro-
tocols have been described using rolling circle
amplification with Φ29 DNA polymerase (Dean et
al., 2002; Nelson et al., 2002). These approaches
appear to be accurate and robust for DNA from lym-
phocytes (Hosono et al., 2003; Tranah et al., 2003).
There are no published data on how these methods
perform with buccal-derived DNA samples.
The goal of this study was to examine the accu-
racy of whole-genome amplification of DNA from
buccal samples in relation to lymphocyte DNA from
the same individuals.
Methods
Paired DNA samples from 30 individuals (DNA from
blood versus amplified buccal DNA) were compared
for five microsatellites, two Variable Number of
Tandem Repeats (VNTRs), and 12 Single Nucleotide
Polymorphisms (SNPs). All SNPs and one VNTR
were genotyped twice to assess replication error.
Thirty volunteers ascertained by convenience sam-
pling donated blood and buccal samples. Genomic
DNA was extracted from approximately 8 ml of
whole blood using a Puregene DNA Purifcation Kit
for whole-blood samples (Gentra Systems). Buccal-
cell DNA was extracted from three sterile cytology
brushes using the Puregene Genomic DNA
Purification Kit for buccal samples (Gentra Systems)
within a week of sampling. Extracted buccal-cell
DNA was amplified (800–1000 ng total yield) using
the GenomiPhi DNA Amplification Kit (Amersham
Biosciences) via the manufacturer’s protocol and
using ~10 ng of DNA to seed the reaction.
Blood and amplified buccal samples from each of the
30 volunteers were genotyped for five microsatellites,
two VNTRs, and 12 SNPs. These markers were scat-
tered across the genome, and most are pertinent to
neuropsychiatric disorders. The five microsatellites were
D10S526, D5S592, FES/FPS, vWA31, and D22S417.
The two VNTRs were located in the dopamine trans-
porter (SLC6A3, 3’ DATVNTR; Kang, Palmatier, &
Kidd, 1999) and serotonin transporter (SLC6A4, 
5-HTTLPR; Lesch et al., 1996). The SNPs were from
dbSNP (rs1042713, rs6277, rs6265, rs4680,
rs2619539, rs1801282, and rs1801133), Applied
Biosystems Inc. (ABI) “Assay-on-Demand” library
(C_7586657, C_8878813, C_304219, and
C_2270166), and deCODE (NRG225133; Stefansson 
et al., 2002).
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All PCR reactions were completed on a MJ
Research PTC-200 DNA Engine. Microsatellite and
VNTR markers were run on an ABI 3730 DNA
Analyzer. ABI GeneMapper (v3.5) was used for semi-
automated genotype calls with verification by an
experienced operator and preestablished quality-
control procedures. SNPs were genotyped using
TaqMan predeveloped assay reagents for allelic dis-
crimination and run on an ABI Prism 7900HT
Sequence Detection System. Genotypes that could not
be easily determined by an experienced operator were
termed no-calls.
This study was reviewed and approved by the
UNC Medical IRB. All samples were anonymized fol-
lowing collection.
Results
We considered three metrics by which to gauge
genotyping accuracy (Table1): no-call proportions,
reproducibility (test–retest), and concordance (blood
versus amplified buccal DNA; Oliphant, Barker,
Stuelpnagel, & Chee, 2002). No-calls were consid-
ered missing data for all reproducibility and
concordance calculations.
No-call Proportions
For SNPs, the overall no-call proportions were 0.28%
(2/720) for DNA from lymphocytes and 0.69% (n =
5/720) for DNA from buccal cells (Fisher’s Exact Test
p = .45). For the remaining genotypes, the overall no-
call proportions were 1.25% (3/240) for DNA from
lymphocytes and 2.50% (n = 6/240) for DNA from
buccal cells (Fisher’s Exact Test p = .50). No individ-
ual sample was consistently not called.
Reproducibility
Reproducibility was determined by repeating geno-
typing for 12 SNPS and 1 VNTR (DATVNTR). SNP
reproducibility was 100% (358/358) for DNA from
blood and 99.15% (352/355) for amplified buccal
DNA (Fisher’s Exact Test p = .12). For the one
VNTR, reproducibility was 100% for DNA from
blood (29/29) and amplified buccal DNA (27/27;
Fisher’s Exact Test p = 1).
Concordance
Concordance was assessed by pairwise comparison of
blood versus amplified buccal DNA from the same
subjects. For the 12 SNPs, the concordance was
99.58% (710/713). For the remaining markers, con-
cordance was 100% (232/232).
Discussion
Our results suggest that whole-genome amplification
of buccal DNA samples via a Φ29 DNA
polymerase/rolling-circle method produces genotypes
that are of comparable quality to those from genomic
DNA from lymphocytes. Specifically, for 12 SNPs, 5
microsatellites, and 2 VNTRs, the no-call proportions
and reproducibility were not significantly different for
lymphocyte and amplified buccal DNA. In addition,
the pairwise concordance for blood and amplified
buccal samples was very high. Previous work sug-
gested that Φ29 DNA polymerase whole-genome
amplification can reasonably be used to amplify DNA
extracted from lymphocytes (Barker et al., 2004; Paez
et al., 2004); our results suggest that these results also
apply to DNA extracted from buccal epithelial cells.
We thought it reasonable to consider no-call geno-
types as missing for two reasons. First, inspection of
the dataset strongly suggested that these were missing
at random with respect to the individual DNA
samples. Second, these no-calls can generally be
resolved with additional genotyping.
These results do not remove the necessity to evalu-
ate the adequacy of buccal whole-genome
amplification for every marker assessed. For example,
markers requiring long PCR may be more likely to
fail on buccal DNA (Roberts, Sullivan, Joyce, &
Kennedy, 2000). Moreover, even if whole genome
amplification works well on average across the
genome, there are likely to be discrete regions or
markers for which it does not work as well.
However, if investigators use appropriate experi-
mental and design precautions, our results suggest that
Φ29 DNA polymerase whole-genome amplification
can be used to increase the numbers of markers that
can be genotyped on DNA from buccal samples col-
lected from twin and other large population registries.
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